| Primary Device ID | 05055273203561 | 
| NIH Device Record Key | 9cc24bde-744b-47fc-bb67-c6d3fa79ff5f | 
| Commercial Distribution Status | In Commercial Distribution | 
| Brand Name | HbA1C | 
| Version Model Number | HA3830 | 
| Catalog Number | HA3830 | 
| Company DUNS | 227530649 | 
| Company Name | RANDOX LABORATORIES LIMITED | 
| Device Count | 1 | 
| DM Exempt | false | 
| Pre-market Exempt | false | 
| MRI Safety Status | Labeling does not contain MRI Safety Information | 
| Human Cell/Tissue Product | false | 
| Device Kit | true | 
| Device Combination Product | false | 
| Single Use | true | 
| Lot Batch | true | 
| Serial Number | false | 
| Manufacturing Date | false | 
| Expiration Date | true | 
| Donation Id Number | false | 
| Contains Natural Rubber Latex | false | 
| Labeled No Natural Rubber Latex | false | 
| RX Perscription | true | 
| OTC Over-The-Counter | false | 
| Phone | +442894451070 | 
| technical.services@randox.com | 
| Special Storage Condition, Specify | Between 0 and 0 *stored protected from extreme heat, light, or freezing. | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Device Issuing Agency | Device ID | 
|---|---|
| GS1 | 05055273203561 [Primary] | 
| LCP | Assay, Glycosylated Hemoglobin | 
| Steralize Prior To Use | false | 
| Device Is Sterile | false | 
| Public Version Status | Update | 
| Device Record Status | Published | 
| Public Version Number | 3 | 
| Public Version Date | 2018-07-06 | 
| Device Publish Date | 2016-09-16 | 
| 05055273208856 | The product is intended for the quantitative in vitro determination of Haemoglobin A1c concentra | 
| 05055273203561 | A Haemoglobin A1c test system is a device intended for the quantitative in vitro determination o | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  HBA1C  78565369  not registered Dead/Abandoned | Novartis AG 2005-02-11 | 
|  HBA1C  78370335  not registered Dead/Abandoned | Novartis AG 2004-02-19 |